TR199800960A2 - Neoplastik lezyonlari önleyen bilesimlerin belirlenmesi için yöntem. - Google Patents
Neoplastik lezyonlari önleyen bilesimlerin belirlenmesi için yöntem.Info
- Publication number
- TR199800960A2 TR199800960A2 TR1998/00960A TR9800960A TR199800960A2 TR 199800960 A2 TR199800960 A2 TR 199800960A2 TR 1998/00960 A TR1998/00960 A TR 1998/00960A TR 9800960 A TR9800960 A TR 9800960A TR 199800960 A2 TR199800960 A2 TR 199800960A2
- Authority
- TR
- Turkey
- Prior art keywords
- inhibitory activity
- prevent
- identifying compounds
- neoplastic lesions
- neoplasia
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 230000003902 lesion Effects 0.000 title 1
- 230000001613 neoplastic effect Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 230000009826 neoplastic cell growth Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 210000000448 cultured tumor cell Anatomy 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 239000003966 growth inhibitor Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Bulus memelilerdeki neoplasia'nin tedavisi amaciyla potansiyel olarak kullanisli bilesimlerin belirlenmesi için bir yöntem saglamaktadir. Bir bilesimin fosfodiesteraz önleyici etkinligi ile birlikte COX önleyici etkinligi belirlenmektedir. Kültürlenmis tümör hücreleri üzerindeki büyüme önleyici ve apoptoz olusturucu etkinlikler de belirlenir. Fosfodiesterazi önleyen, büyümeyi önleyen ve apoptoz olusturan, ama fazla bir prostaglandin önleyici etkinlik göstermeyen bilesimler neoplasia'nin tedavisi için arzu edilen bilesimlerdir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/866,027 US5858694A (en) | 1997-05-30 | 1997-05-30 | Method for identifying compounds for inhibition of cancerous lesions |
US4673998A | 1998-03-24 | 1998-03-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
TR199800960A2 true TR199800960A2 (tr) | 1998-12-21 |
TR199800960A3 TR199800960A3 (tr) | 1998-12-21 |
Family
ID=26724247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1998/00960A TR199800960A3 (tr) | 1997-05-30 | 1998-05-29 | Neoplastik lezyonlari önleyen bilesimlerin belirlenmesi için yöntem. |
Country Status (16)
Country | Link |
---|---|
US (3) | US6500610B1 (tr) |
EP (2) | EP1038523A3 (tr) |
JP (3) | JP3053381B2 (tr) |
KR (1) | KR100304859B1 (tr) |
AT (1) | ATE198771T1 (tr) |
AU (1) | AU709666B2 (tr) |
CA (1) | CA2238283C (tr) |
CZ (1) | CZ295868B6 (tr) |
DE (2) | DE881300T1 (tr) |
DK (1) | DK0881300T3 (tr) |
ES (1) | ES2132055T3 (tr) |
HK (1) | HK1012196A1 (tr) |
IL (1) | IL124699A (tr) |
NO (1) | NO321717B1 (tr) |
TR (1) | TR199800960A3 (tr) |
TW (1) | TW591111B (tr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040009464A1 (en) * | 1998-10-15 | 2004-01-15 | Li Liu | Methods for identifying compounds for inhibition of neoplastic lesions, and pharmacetical compositions containing such compounds |
US20020009764A1 (en) * | 1999-10-08 | 2002-01-24 | W. Joseph Thompson | Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
IL132366A0 (en) * | 1998-10-15 | 2001-03-19 | Cell Pathways Inc | Methods for identifying compounds for inhibition of neoplastic lesions and pharmaceutical compositions containing such compounds |
US20050244914A1 (en) * | 1999-10-08 | 2005-11-03 | Li Liu | Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
DE10060388A1 (de) * | 2000-12-05 | 2002-06-06 | Merck Patent Gmbh | Verwendung von Pyrazolo [4,3-d]pyrimidinen |
FR2824334B1 (fr) | 2001-05-03 | 2003-10-10 | Coletica | Procede pour tester une substance eventuellement active dans le domaine de la lipolyse et son utilisation principalement cosmetique |
JP2005516586A (ja) * | 2001-07-20 | 2005-06-09 | ボード オブ トラスティーズ オブ ザ ユニヴァースティ オブ イリノイ | 癌の処置に対する遺伝子標的を同定するための試薬および方法 |
DE10135815A1 (de) * | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
WO2003012030A2 (en) * | 2001-08-01 | 2003-02-13 | University Of Utah, Technology Transfer Office | Isoform-selective inhibitors and activators of pde3 cyclic |
WO2003038430A1 (fr) * | 2001-10-29 | 2003-05-08 | Takeda Chemical Industries, Ltd. | Technique d'analyse |
US20050048573A1 (en) * | 2003-02-03 | 2005-03-03 | Plexxikon, Inc. | PDE5A crystal structure and uses |
US7711584B2 (en) | 2003-09-04 | 2010-05-04 | Hartford Fire Insurance Company | System for reducing the risk associated with an insured building structure through the incorporation of selected technologies |
EP1690852A1 (en) * | 2003-12-01 | 2006-08-16 | Reverse Proteomics Research Institute Co., Ltd | Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto |
US7585859B2 (en) * | 2004-05-06 | 2009-09-08 | Plexxikon, Inc. | PDE4B inhibitors and uses therefor |
EP1786813A2 (en) * | 2004-09-03 | 2007-05-23 | Plexxikon, Inc. | Bicyclic heteroaryl pde4b inhibitors |
WO2006074443A2 (en) | 2005-01-07 | 2006-07-13 | The Johns Hopkins University | Pde5 inhibitor compositions and methods for immunotherapy |
WO2006097459A1 (en) * | 2005-03-14 | 2006-09-21 | Nycomed Gmbh | Method for preventing cardiovascular diseases |
EP1968616A4 (en) * | 2006-01-04 | 2009-10-21 | Southern Res Inst | DERIVATIVES OF SULINDAC, USE AND PREPARATION THEREOF |
JP2007224007A (ja) * | 2006-03-27 | 2007-09-06 | Univ De Santiago De Compostela | yessotoxinsのヒト腫瘍細胞増殖抑制剤としての治療的な使用 |
US8673914B2 (en) | 2011-03-28 | 2014-03-18 | St. John's University | Use of phosphodiesterase inhibitors for treating multidrug resistance |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
Family Cites Families (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE274218C (tr) | ||||
GB807826A (en) | 1955-03-14 | 1959-01-21 | Thomae Gmbh Dr K | Derivatives of pyrimido[5,4-d] pyrimidine and production thereof |
US3031450A (en) | 1959-04-30 | 1962-04-24 | Thomae Gmbh Dr K | Substituted pyrimido-[5, 4-d]-pyrimidines |
AT290523B (de) | 1962-01-05 | 1971-06-11 | Merck & Co Inc | Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren |
US3322755A (en) | 1964-03-10 | 1967-05-30 | Boehringer Sohn Ingelheim | Basic-substituted 1, 2, 3, 4-tetrahydropyrimido [5, 4-d]-pyrimidines |
US3812127A (en) | 1966-10-31 | 1974-05-21 | Pfizer | 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters |
GB1199768A (en) | 1966-10-31 | 1970-07-22 | Pfizer & Co C | Nitrogen Heterocycles and process for their preparation |
US3517005A (en) | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
US3752826A (en) | 1970-01-26 | 1973-08-14 | Mcneilab Inc | Aroyl substituted pyrroles |
US3654349A (en) | 1970-05-01 | 1972-04-04 | Merck & Co Inc | Substituted indenyl acetic acids |
US3647858A (en) | 1970-05-01 | 1972-03-07 | Merck & Co Inc | Process for preparing 1-benzylidene-3-indenyl acetic acids |
US3819631A (en) | 1970-12-15 | 1974-06-25 | May & Baker Ltd | Azapurinones |
GB1493685A (en) | 1970-12-15 | 1977-11-30 | May & Baker Ltd | 8-azapurinones |
US3780040A (en) | 1972-06-02 | 1973-12-18 | R Schnettler | 2-substituted-3,4-dihydroquinazolines |
JPS536156B2 (tr) | 1972-10-30 | 1978-03-04 | ||
JPS5825980B2 (ja) * | 1976-02-12 | 1983-05-31 | ヤマサ醤油株式会社 | サイクリックヌクレオチドの定量法 |
US4001237A (en) | 1976-02-18 | 1977-01-04 | Bristol-Myers Company | Oxazole, isoxazole, thiazole and isothiazole amides |
US4060615A (en) | 1976-02-18 | 1977-11-29 | Mead Johnson & Company | 2-Piperazinyl-6,7-dimethoxyquinazolines |
US4001238A (en) | 1976-02-18 | 1977-01-04 | Bristol-Myers Company | 1,3,4-oxadiazole amides |
US4076711A (en) | 1976-04-05 | 1978-02-28 | Schering Corporation | Triazolo [4,5-d]-pyrimidines |
US4171363A (en) | 1977-02-22 | 1979-10-16 | Bristol-Myers Company | 1,2,3-Thiadiazole process |
US4101548A (en) | 1977-02-22 | 1978-07-18 | Bristol-Myers Company | 1,2,3-Thiadiazole amides |
US4079057A (en) | 1977-05-31 | 1978-03-14 | Bristol-Myers Company | Selective immunosuppressive agents |
US4102885A (en) | 1977-06-20 | 1978-07-25 | Bristol-Myers Company | Process for preparing 2,4-dihaloquinazolines |
US4098788A (en) | 1977-06-20 | 1978-07-04 | Bristol-Myers Company | Process for preparing quinazolines |
US4138561A (en) | 1977-09-30 | 1979-02-06 | Bristol-Myers Company | Cyanocarboxamidines and quinazoline process |
US4146718A (en) | 1978-04-10 | 1979-03-27 | Bristol-Myers Company | Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides |
US4209623A (en) | 1978-06-07 | 1980-06-24 | Bristol-Myers Company | Pyrimidine-5-N-(1H-tetrazol-5-yl)-carboxamides |
US4208521A (en) | 1978-07-31 | 1980-06-17 | Bristol-Myers Company | Process for the preparation of imidazo[2,1-b]quinazolinones |
US4161595A (en) | 1978-10-02 | 1979-07-17 | Bristol-Myers Company | Levulinic acid salt |
DE2845766A1 (de) | 1978-10-18 | 1980-04-30 | Schering Ag | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
JPS5653659A (en) | 1979-10-09 | 1981-05-13 | Mitsubishi Yuka Yakuhin Kk | Blood platelet coagulation suppressing agent |
GB2063249A (en) | 1979-10-09 | 1981-06-03 | Mitsubishi Yuka Pharma | 4-Phenylphthalazine derivatives |
US4423075A (en) | 1980-06-19 | 1983-12-27 | Ayerst, Mckenna & Harrison Inc. | Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic acid |
JPS57167974A (en) | 1981-04-09 | 1982-10-16 | Mitsubishi Yuka Yakuhin Kk | Preparation of 4-phenylphthalazine derivative |
DE3131365A1 (de) | 1981-08-07 | 1983-02-24 | Henkel KGaA, 4000 Düsseldorf | Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit |
US5250535A (en) | 1982-02-01 | 1993-10-05 | Syntex Inc. | Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent |
US4460591A (en) | 1982-08-26 | 1984-07-17 | Sri International | 8,10-Dideazaminopterins |
FI94133C (fi) * | 1985-04-19 | 1995-07-25 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi |
US4837239A (en) | 1985-08-23 | 1989-06-06 | Syntex (U.S.A.) Inc. | Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins |
DE3770095D1 (de) | 1986-08-21 | 1991-06-20 | Pfizer | Chinazolindione und pyridopyrimidindione. |
CA1303037C (en) | 1987-02-02 | 1992-06-09 | Smith Kline & French Laboratories Limited | Purinone derivatives as bronchodilators vasodilators and anti-allergic agents |
AU3192289A (en) | 1988-02-08 | 1989-08-25 | Schering Corporation | Nucleosidetype compounds which are phosphodiesterase inhibitors |
US5091431A (en) | 1988-02-08 | 1992-02-25 | Schering Corporation | Phosphodiesterase inhibitors |
US5254571A (en) | 1988-04-21 | 1993-10-19 | Smith Kline & French Laboratories Ltd. | Chemical compounds |
GB8814352D0 (en) | 1988-06-16 | 1988-07-20 | Smith Kline French Lab | Chemical compounds |
DE68908786T2 (de) | 1988-06-16 | 1994-03-17 | Smith Kline French Lab | Condensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. |
US5075310A (en) | 1988-07-01 | 1991-12-24 | Smith Kline & French Laboratories, Ltd. | Pyrimidone derivatives as bronchodilators |
US4923874A (en) | 1988-07-21 | 1990-05-08 | G. D. Searle & Co. | Use of 8-azapurin-6-one derivatives for control of hypertension |
GB8817651D0 (en) | 1988-07-25 | 1988-09-01 | Smith Kline French Lab | Chemical compounds |
GB8827988D0 (en) | 1988-11-30 | 1989-01-05 | Smith Kline French Lab | Chemical compounds |
US4971972A (en) | 1989-03-23 | 1990-11-20 | Schering Corporation | Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion |
GB8909560D0 (en) | 1989-04-26 | 1989-06-14 | Smith Kline French Lab | Chemical compounds |
US5376683A (en) | 1989-07-14 | 1994-12-27 | Schering Aktiengesellschaft | Δ8- and Δ9-prostaglandin derivatives, process for their production and their pharmaceutical use |
GB8923131D0 (en) | 1989-10-13 | 1989-11-29 | Smith Kline French Lab | Chemical compounds |
US5091430A (en) | 1990-03-13 | 1992-02-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | O6 -substituted guanine compounds and methods for depleting O6 -alkylguanine-DNA alkyltransferase levels |
GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
ZA914727B (en) | 1990-06-21 | 1992-03-25 | Schering Corp | Polycyclic guanine derivatives |
ZA916646B (en) | 1990-08-23 | 1992-07-29 | Synphar Lab Inc | Novel isocarbostiryl compounds and anti-tumor use thereof |
US5175151A (en) | 1990-09-07 | 1992-12-29 | Schering Corporation | Antiviral compounds and antihypertensive compounds |
AU659106B2 (en) | 1990-11-06 | 1995-05-11 | Fgn, Inc. | Method for treating colonic polyps by the use of esters and amides of substituted phenyl and pyridyl amino carboxylates |
AU658373B2 (en) | 1990-11-06 | 1995-04-13 | Fgn, Inc. | Esters and amides of substituted pyrrole acetic acids |
AU650914B2 (en) | 1990-11-06 | 1994-07-07 | Fgn, Inc. | Esters and amides of substituted phenyl acetic acids |
AU650689B2 (en) | 1990-11-06 | 1994-06-30 | Fgn, Inc. | Esters and amides of substituted indenyl acetic acids |
AU659107B2 (en) | 1990-11-06 | 1995-05-11 | Fgn, Inc. | Method for treating colonic polyps by the use of esters and amides of substituted fused ring phenyl acetic acids |
US5401774A (en) * | 1991-03-08 | 1995-03-28 | University Of Arizona | Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds |
EP0508586B1 (en) * | 1991-03-08 | 1995-05-31 | Fgn, Inc. | Substituted indenyl compounds |
US5239083A (en) | 1991-03-11 | 1993-08-24 | Kyowa Hakko Kogyo Co., Ltd. | Indole derivatives which inhibit steroid 5α reductase |
US5223501A (en) | 1991-05-10 | 1993-06-29 | Merck & Co., Inc. | Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists |
GB9114760D0 (en) | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
PT100905A (pt) | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
GB9121028D0 (en) | 1991-10-03 | 1991-11-13 | Pfizer Ltd | Therapeutic agents |
GB9126260D0 (en) | 1991-12-11 | 1992-02-12 | Pfizer Ltd | Therapeutic agents |
US5731167A (en) | 1992-01-17 | 1998-03-24 | The United States Of America As Represented By The Department Of Health And Human Services | Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
JP2657760B2 (ja) | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | 4−アミノキナゾリン誘導体およびそれを含有する医薬品 |
CA2140440A1 (en) | 1992-08-06 | 1994-02-17 | Ellen M. Dobrusin | 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
EP0682109A4 (en) | 1993-01-29 | 1997-06-04 | Taisho Pharmaceutical Co Ltd | CYCLIC NUCLEOTIDASE AND METHOD FOR PRODUCING THE SAME. |
US6156312A (en) * | 1993-06-23 | 2000-12-05 | Leskovar; Peter | Agents, affecting the hyperactivated immunological effector cells |
DE4330177A1 (de) | 1993-08-31 | 1995-03-02 | Schering Ag | Neue 9-Chlor-prostaglandin-derivate |
EP0669324A4 (en) | 1993-09-10 | 1996-04-03 | Eisai Co Ltd | CHINAZOLIN DERIVATIVES. |
JPH09507300A (ja) * | 1994-01-06 | 1997-07-22 | テラピン テクノロジーズ,インコーポレイテッド | 標的の代用物および改良された参照パネル |
AU701529B2 (en) * | 1994-04-05 | 1999-01-28 | Purdue Research Foundation | NADH oxidase as a target in diagnosis and therapy |
US5776962A (en) * | 1994-08-03 | 1998-07-07 | Cell Pathways, Inc. | Lactone compounds for treating patient with precancerous lesions |
US5696159A (en) | 1994-08-03 | 1997-12-09 | Cell Pathways, Inc. | Lactone compounds for treating patients with precancerous lesions |
DE19501481A1 (de) | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,8-Disubstituierte Chinazolinone |
US5674876A (en) | 1995-01-20 | 1997-10-07 | Research Development Foundation | ρ-heteroatom-substituted phenols and uses thereof |
US5488055A (en) | 1995-03-10 | 1996-01-30 | Sanofi Winthrop Inc. | Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof |
US5614530A (en) | 1995-03-10 | 1997-03-25 | Sterling Winthrop Inc. | Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof |
DE19518082A1 (de) | 1995-05-17 | 1996-11-21 | Merck Patent Gmbh | 4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one |
US5874440A (en) | 1995-06-07 | 1999-02-23 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives |
GB9526246D0 (en) | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526245D0 (en) | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526243D0 (en) | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
US5798246A (en) | 1996-03-25 | 1998-08-25 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterase |
US5998477A (en) * | 1996-06-13 | 1999-12-07 | Cell Pathways Inc. | Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions |
US6063818A (en) * | 1996-06-13 | 2000-05-16 | Cell Pathways Inc. | Substituted benzylidene indenyl formamides, acetamides and propionamides |
WO1998009523A1 (en) * | 1996-09-05 | 1998-03-12 | Massachusetts Institute Of Technology | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
US5869519A (en) | 1996-12-16 | 1999-02-09 | Idun Pharmaceuticals, Inc. | C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
US6294585B1 (en) | 1996-09-18 | 2001-09-25 | Applied Genetics Incorporated Dermatics | Treatment of neurodegenerative diseases |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
US5932465A (en) | 1997-10-16 | 1999-08-03 | Icos Corporation | Phosphodiesterase 8A |
US5922595A (en) | 1997-12-09 | 1999-07-13 | Incyte Pharmaceuticals, Inc. | Cyclic GMP phosphodiesterase |
US5852035A (en) | 1997-12-12 | 1998-12-22 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines |
US5942520A (en) | 1998-01-27 | 1999-08-24 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines |
US6200771B1 (en) * | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
US6235782B1 (en) * | 1998-11-12 | 2001-05-22 | Rifat Pamukcu | Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
US6235776B1 (en) * | 1998-11-12 | 2001-05-22 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
-
1998
- 1998-05-20 CA CA002238283A patent/CA2238283C/en not_active Expired - Fee Related
- 1998-05-25 TW TW087108072A patent/TW591111B/zh not_active IP Right Cessation
- 1998-05-28 KR KR1019980019380A patent/KR100304859B1/ko not_active IP Right Cessation
- 1998-05-28 CZ CZ19981651A patent/CZ295868B6/cs not_active IP Right Cessation
- 1998-05-29 AT AT98304247T patent/ATE198771T1/de not_active IP Right Cessation
- 1998-05-29 AU AU69794/98A patent/AU709666B2/en not_active Ceased
- 1998-05-29 EP EP00112020A patent/EP1038523A3/en not_active Withdrawn
- 1998-05-29 DE DE0881300T patent/DE881300T1/de active Pending
- 1998-05-29 IL IL12469998A patent/IL124699A/xx not_active IP Right Cessation
- 1998-05-29 DE DE69800488T patent/DE69800488T2/de not_active Expired - Lifetime
- 1998-05-29 DK DK98304247T patent/DK0881300T3/da active
- 1998-05-29 ES ES98304247T patent/ES2132055T3/es not_active Expired - Lifetime
- 1998-05-29 TR TR1998/00960A patent/TR199800960A3/tr unknown
- 1998-05-29 NO NO19982477A patent/NO321717B1/no unknown
- 1998-05-29 EP EP98304247A patent/EP0881300B1/en not_active Expired - Lifetime
- 1998-05-29 JP JP10150033A patent/JP3053381B2/ja not_active Expired - Fee Related
- 1998-12-16 HK HK98113546A patent/HK1012196A1/xx not_active IP Right Cessation
-
1999
- 1999-07-02 JP JP18961599A patent/JP3234818B2/ja not_active Expired - Lifetime
- 1999-10-08 US US09/414,625 patent/US6500610B1/en not_active Expired - Fee Related
-
2000
- 2000-02-22 JP JP2000044184A patent/JP2000198746A/ja active Pending
-
2002
- 2002-01-07 US US10/040,776 patent/US20030004093A1/en not_active Abandoned
- 2002-09-24 US US10/252,983 patent/US20030190686A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199800960A2 (tr) | Neoplastik lezyonlari önleyen bilesimlerin belirlenmesi için yöntem. | |
ZA987491B (en) | Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation | |
BG102003A (en) | PYRIDO/2,3-d/PYRIMIDINES FOR THE INHIBITION OF CELLULAR PROLIFERATION CAUSED BY PROTEINTHYROSIKINASE | |
IL139056A0 (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
PA8436001A1 (es) | Inhibidores de naaladasa. | |
TR200002445T2 (tr) | Fosfolipaz inhibitörleri. | |
ES2179490T3 (es) | Derivados de 1,2,4-triazolo(3,4-a)ftalazina sustituidos como ligandos de gaba alfa 5. | |
NO20002979L (no) | Undersøkelse av human papillomavirus-relatert sykdom | |
BG102945A (en) | Carbamide derivatives as inhibitors of enzyme inosine-5'-monophosphate dehydrogenase | |
EE9900105A (et) | Bensonaftüridiinid bronhiaalravimitena | |
BG103096A (en) | Thrombin inhibitors | |
DE69333931D1 (de) | Verwendung von Krillenzymen zur Behandlung von Zahnbelag | |
ATE218855T1 (de) | Wasserdispersible therapeutische carotenoid verbindungen | |
AR022583A1 (es) | Secuencias antitumorales anti-sentido dirigidas contra los componentes r1 y r2 de la reductasa de los ribonucleotidos | |
NZ330451A (tr) | ||
ATE256673T1 (de) | Chirale phenyldihydrofuranone als pde-iv inhibitoren | |
IL189502A0 (en) | Methods and compositions for inhibiting neoplastic cell growth | |
SE9604582D0 (sv) | Novel compounds | |
MXPA02008014A (es) | Composiciones inhibidoras de tumores de 1-nitroacridina. | |
CA2274116A1 (en) | Use, of an inhibitor of thioredoxin, for inhibiting tumor growth | |
MY117925A (en) | Compounds for the inhibition of farnesyl protein transferase. | |
SI0937075T1 (en) | New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors. | |
TR200002352T2 (tr) | Antifolatları yapmakta faydalı yöntemler ve ara maddeler | |
TR199701011A2 (tr) | 1-karba-(detia)-sefalosforin türevleri. | |
PA8436101A1 (es) | Inhibidores de la actividad de la enzima naaladasa. |